Progestogen-only Pills

FSRH Clinical Guideline: Progestogen-only Pills (August 2022, Amended October 2022)

03 October 2022

This guideline provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only contraceptive pills. It is intended for any health care professional or health service providing contraceptive care in the UK.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date

FSRH Guideline: Progestogen-only Pills (August 2022, Amended October 2022) (Evidence relocated)

03 October 2022

This guideline provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only contraceptive pills. It is intended for any healthcare professional or health service providing contraceptive care in the UK. In this version of the POP Guideline, the supporting evidence for the recommendations has been removed from the main text and located in an appendix for ease of reading. This document is written for FSRH members and requires you to log in to access it.

This resource is available to members/candidates of FSRH.

This document is up-to-date

FSRH CEU Guidance: Progestogen-only Pills Quick Reference Summary (August 2022)

23 August 2022

This summary has been written as a quick reference guide to help busy clinicians to give clear, safe advice on progestogen-only contraceptive pills. Please refer to the full 2022 FSRH Progestogen-only Pills Clinical Guideline for further information and supporting evidence for this advice. This document is written for FSRH members and requires you to log in to access it.

This resource is available to members/candidates of FSRH.

This document is up-to-date

FSRH Guideline-related CPD Q&A: Progestogen-only Pills (August 2022)

23 August 2022

Login to view this document. 1 CPD credit can be claimed for reading the guidance. 1 CPD credit can be claimed for answering the questions.

This resource is available to members/candidates of FSRH.

This document is up-to-date

FSRH Clinical Statement - DSG-POP as Pharmacy Medication

21 July 2021

This FSRH Statement reviews two desogestrel 75mcg progestogen-only pill (POP) available over-the-counter as Pharmacy Medicines.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date